| http://dbpedia.org/ontology/abstract
|
HP-505是一种有机化合物，化学式为C18H19NO。它是由研发的三重再摄取抑制剂。HP-505在小鼠试验中发现是诱导的的有效抑制剂，这表明它可能具有抗抑郁活性。
, HP-505 is a triple reuptake inhibitor that was investigated by Hoechst-Roussel Pharmaceuticals. In mice, HP-505 was a potent inhibitor of tetrabenazine-induced ptosis which may indicate antidepressant activity.
|
| http://dbpedia.org/ontology/casNumber
|
59142-94-8
|
| http://dbpedia.org/ontology/chEMBL
|
436281
|
| http://dbpedia.org/ontology/pubchem
|
191510
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/HP_505.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
71370706
|
| http://dbpedia.org/ontology/wikiPageLength
|
3667
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1123080600
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/File:HP-365_synthesis.svg +
, http://dbpedia.org/resource/Triple_reuptake_inhibitor +
, http://dbpedia.org/resource/HP-365 +
, http://dbpedia.org/resource/Category:Piperidines +
, http://dbpedia.org/resource/Norepinephrine +
, http://dbpedia.org/resource/Category:Serotonin%E2%80%93norepinephrine%E2%80%93dopamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Category:Drugs_not_assigned_an_ATC_code +
, http://dbpedia.org/resource/Category:Spiro_compounds +
, http://dbpedia.org/resource/Dopamine_transporter +
, http://dbpedia.org/resource/Serotonin +
, http://dbpedia.org/resource/Norepinephrine_transporter +
, http://dbpedia.org/resource/Anticholinergic +
, http://dbpedia.org/resource/Category:Isobenzofurans +
, http://dbpedia.org/resource/Serotonin_transporter +
, http://dbpedia.org/resource/Ptosis +
, http://dbpedia.org/resource/Dopamine +
, http://dbpedia.org/resource/Tetrabenazine +
, http://dbpedia.org/resource/Hoechst-Marion-Roussel +
|
| http://dbpedia.org/property/c
|
18
|
| http://dbpedia.org/property/casNumber
|
59142
|
| http://dbpedia.org/property/chembl
|
436281
|
| http://dbpedia.org/property/chemspiderid
|
166303
|
| http://dbpedia.org/property/h
|
19
|
| http://dbpedia.org/property/iupacName
|
3
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/pubchem
|
191510
|
| http://dbpedia.org/property/smiles
|
C1=CC=CC=C1
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
ZFJQWOMHWFYLPD-UHFFFAOYSA-N
|
| http://dbpedia.org/property/width
|
130
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Piperidines +
, http://dbpedia.org/resource/Category:Drugs_not_assigned_an_ATC_code +
, http://dbpedia.org/resource/Category:Isobenzofurans +
, http://dbpedia.org/resource/Category:Spiro_compounds +
, http://dbpedia.org/resource/Category:Serotonin%E2%80%93norepinephrine%E2%80%93dopamine_reuptake_inhibitors +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/HP-505?oldid=1123080600&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/HP-365_synthesis.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/HP_505.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/HP-505 +
|
| owl:sameAs |
http://dbpedia.org/resource/HP-505 +
, https://global.dbpedia.org/id/GVa97 +
, http://zh.dbpedia.org/resource/HP-505 +
, http://www.wikidata.org/entity/Q82958968 +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
HP-505是一种有机化合物，化学式为C18H19NO。它是由研发的三重再摄取抑制剂。HP-505在小鼠试验中发现是诱导的的有效抑制剂，这表明它可能具有抗抑郁活性。
, HP-505 is a triple reuptake inhibitor that was investigated by Hoechst-Roussel Pharmaceuticals. In mice, HP-505 was a potent inhibitor of tetrabenazine-induced ptosis which may indicate antidepressant activity.
|
| rdfs:label |
HP-505
|
